[Ocular burns].
Merle H, Gérard M, Schrage N.
J Fr Ophtalmol. 2008 Sep;31(7):723-34. doi: 10.1016/s0181-5512(08)74391-2.
Human Umbilical Cord-Derived Mesenchymal Stem Cells Promote Corneal Epithelial Repair In Vitro.
Kacham S, Bhure TS, Eswaramoorthy SD, Naik G, Rath SN, Parcha SR, Basu S, Sangwan VS, Shukla S.
Cells. 2021 May 19;10(5):1254. doi: 10.3390/cells10051254.
Chemical injuries of the eye: current concepts in pathophysiology and therapy.
Wagoner MD.
Surv Ophthalmol. 1997 Jan-Feb;41(4):275-313. doi: 10.1016/s0039-6257(96)00007-0.
Emergency treatment of chemical and thermal eye burns.
Kuckelkorn R, Schrage N, Keller G, Redbrake C.
Acta Ophthalmol Scand. 2002 Feb;80(1):4-10. doi: 10.1034/j.1600-0420.2002.800102.x.
[Immunohistochemical localization of acidic and basic fibroblast growth factor through corneal neovascularization in vivo and in vitro].
Hayashi N, Nakayasu K, Okisaka S.
Nippon Ganka Gakkai Zasshi. 1996 Aug;100(8):587-91.
Inflammation, vascularization and goblet cell differences in LSCD: Validating animal models of corneal alkali burns.
Kethiri AR, Raju E, Bokara KK, Mishra DK, Basu S, Rao CM, Sangwan VS, Singh V.
Exp Eye Res. 2019 Aug;185:107665. doi: 10.1016/j.exer.2019.05.005. Epub 2019 May 13.
[Clinical aspects of corneal burns].
Borderie V.
J Fr Ophtalmol. 2004 Dec;27(10):1170-4. doi: 10.1016/s0181-5512(04)96291-2.
Release of soluble tumor necrosis factor receptor 1 from corneal epithelium by TNF-alpha-converting enzyme-dependent ectodomain shedding.
Sakimoto T, Yamada A, Sawa M.
Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4618-21. doi: 10.1167/iovs.08-2669. Epub 2009 Apr 30.
Therapeutic potential of trichostatin A to control inflammatory and fibrogenic disorders of the ocular surface.
Kitano A, Okada Y, Yamanka O, Shirai K, Mohan RR, Saika S.
Mol Vis. 2010 Dec 31;16:2964-73.
The effects of chemical injury on the ocular surface.
Pfister RR.
Ophthalmology. 1983 Jun;90(6):601-9. doi: 10.1016/s0161-6420(83)34509-7.
